Featuring the same content as the Tarascon Pocket Pharmacopoeia 2017 Classic Shirt-Pocket Edition but with larger, easier-to-read print, the Large Print Edition continues its tradition as the leading portable drug reference packed with vital drug information to help clinicians make better decisions at point of care.
Here are 10 things you may not know about Tarascon:
- The Tarascon Series is named after the Tarascon castle in France where the original author was visiting when he decided to turn his “cheat sheet” of drug information into a published book.
- Every year we include a trivia question in the Classic and Deluxe books. The first 25 people who find it and respond with the correct answer get a prize.
- You can now find Tarascon Pharmacopoeia drug information in EvidenceCare's unique online decision support tool for providers
Ask anyone at Tarascon, our favorite time of year is when we get to announce the new editions of the Tarascon Pharmacopoeias. The 2017 editions of the most popular and trusted source of portable drug information are here! The Tarascon Pharmacopoeia features new drugs that reflect the updated FDA Pregnancy and Lactation Labeling Rule (PLLR) and of course has been updated with the latest FDA Guidelines and new drug information.
EvidenceCare, a Nashville-based decision support tool for healthcare providers, announces the integration of drug information from Tarascon Pharmacopoeia, the most popular and trusted source of portable drug information since 1987. The integration provides EvidenceCare the opportunity to deliver content that has been relied upon by Providers worldwide for nearly three decades. EvidenceCare presents the information in a format that is easy-to-access and is personalized to each unique patient.
The highly anticipated fourth edition of the must-have ECG interpretation resource is now available. The Complete Guide to ECGs has been developed as a unique and practical means for physicians, physicians-in-training, and other medical professionals to improve their ECG interpretation skills. The highly interactive format and comprehensive scope of information are also ideally suited for physicians preparing for the American Board of Internal Medicine (ABIM) Cardiovascular Disease or Internal Medicine Board Exams, the American College of Cardiology ECG proficiency test, and other exams requiring ECG interpretation.
Schizophrenia and its related conditions are all too common among young adults and are prevalent in about 1% of the general population. This is a devastating disorder of thinking; if gone undetected and thus untreated it can lead to robbing an individual of his or her life's goals and aspirations as it develops. If unchecked, it can lead to either suicidal or violent behavior towards others because the affected individual may become plagued by increasing paranoia, bothersome auditory hallucinations commanding various actions, and a general withdrawal from reality. Lately some unfortunate cases of developing schizophrenia have made the news because of the tragic and deadly events they initiated. These have spurred controversial gun control debates and have brought mental illness to the forefront of these debates about government legislation nationally.
To celebrate this year’s Rare Disease Day, The Tarascon Team is offering a One Day App Sale on all new downloads of our Tarascon Pharmacopoeia mobile app for iPhone, iPad, and Android devices. Enjoy 25% off on Monday, February 29th!
The first week of October brings awareness to mental illness and highlights issues, provides support, and works to fight stigma associated with mental health. Did you know, 1 in 17 (14 million) Americans live with a major mental illness like depression, schizophrenia, or bi-polar disorder? According to NAMI (National Awareness on Mental Illness), 1 in 4 (62 million) persons are affected by mental illness, 20% of teens 13-18 have a mental illness, and 18% of adults (42 million) cope with anxiety disorders.
Prostate cancer is common. In 2012, there were an estimated 2,795, 592 (over 2.5 million) men living with prostate cancer in the United States. It is estimated that there will be 220,800 new cases of prostate cancer in 2015, accounting for 13.3% of all new cancer cases. Approximately 27,540 men will die from prostate cancer in 2015. (SEER Stat fact sheets: prostate cancer) It is likely that you know someone, a spouse, significant other, family member or friend with prostate cancer.